Bharat Parenterals Share Price
1505.10-29.85 (-1.94%)
+11.08% past 1 Year
Bharat Parenterals limited is dealing in Manufacturing of Pharmaceutical Formulations. The company has established its own range of products in domestic & international markets. Its main vision is commited to
Corporate filings & documents
Announcements
Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19 2026.
1 week agoPlease find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19 2026.
1 week agoPlease find the enclosed copy of the letter dispatched by the company to the shareholders (whose email id not registered) for providing details to access the Annual Report for FY 2025-26.
1 week agoPlease find the enclosed copy of the letter dispatched by the company to the shareholders (whose email id not registered) for providing details to access the Annual Report for FY 2025-26.
1 week agoIntimation of Record Date for the purpose of Payment of Dividend for the FY 2025-26.
1 week agoIntimation of Record Date for the purpose of Payment of Dividend for the FY 2025-26.
1 week agoAnnual Report for the Financial Year 2025-26
1 week agoAnnual Report for the Financial Year 2025-26
1 week agoNotice of 33rd Annual General Meeting of the Company.
1 week agoNotice of 33rd Annual General Meeting of the Company.
1 week agoIntimation for publication of Pre-Newspaper Advertisement of the 33rd Annual General Meeting of the Company.
1 week agoIntimation for publication of Pre-Newspaper Advertisement of the 33rd Annual General Meeting of the Company.
1 week agoIntimation regarding permission to trade and Admission of Equity Shares to dealing on the National Stock Exchange of India Limited.
2 weeks agoIntimation regarding permission to trade and Admission of Equity Shares to dealing on the National Stock Exchange of India Limited.
2 weeks agoPlease find the enclosed newspaper notice to the physical Shareholders informing them about the special window open for re-lodging the transfer deed.
3 weeks agoPlease find the enclosed newspaper notice to the physical Shareholders informing them about the special window open for re-lodging the transfer deed.
3 weeks agoPress release on Update on Expansion and Enhancement of the facility of Varenyam Biolifesciences Pvt Ltd a Wholly Owned Subsidiary Company of Bharat Parenterals Limited
3 weeks agoPress release on Update on Expansion and Enhancement of the facility of Varenyam Biolifesciences Pvt Ltd a Wholly Owned Subsidiary Company of Bharat Parenterals Limited
3 weeks agoIntimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR) Regulations 2015.
3 weeks agoIntimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR) Regulations 2015.
3 weeks agoCopy of newspaper advertisement for the Unaudited Financial Results for the Quarter ended on June 30 2026.
4 weeks agoCopy of newspaper advertisement for the Unaudited Financial Results for the Quarter ended on June 30 2026.
4 weeks agoInvestor Presentation for the Quarter ended on June 30 2026
4 weeks agoInvestor Presentation for the Quarter ended on June 30 2026
4 weeks agoRe-appointment of Mr. Hemang Shah as Executive Director of the Company Subject to approval of Shareholders in enuing AGM.
4 weeks agoRe-appointment of Mr. Hemang Shah as Executive Director of the Company Subject to approval of Shareholders in enuing AGM.
4 weeks agoUnaudited Financial Results for the quarter ended on June 30 2026.
4 weeks agoUnaudited Financial Results for the quarter ended on June 30 2026.
4 weeks agoOutcome of Board Meeting held on August 05 2026
4 weeks agoOutcome of Board Meeting held on August 05 2026
4 weeks agoNewspaper Advertisement under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.
1 month agoNewspaper Advertisement under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.
1 month agoBharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial results for the Quarter ended on June 30 2026.
1 month agoBharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial results for the Quarter ended on June 30 2026.
1 month agoCompliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended on June 30 2026
1 month agoCompliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended on June 30 2026
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares & Stock Pvt Ltd
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares & Stock Pvt Ltd
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares and Stock Pvt Ltd
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares and Stock Pvt Ltd
2 months agoDisclosure Under Regulation 7(2) of SEBI (PIT) Regulations 2015
2 months agoDisclosure Under Regulation 7(2) of SEBI (PIT) Regulations 2015
2 months agoNewspaper Advertisement Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoNewspaper Advertisement Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoIntimation for the closure of Trading Window in terms of SEBI (Prohibition of Insider Trading) Regulations 2015.
2 months agoIntimation for the closure of Trading Window in terms of SEBI (Prohibition of Insider Trading) Regulations 2015.
2 months agoDisclosure under regulation 7(2) of SEBI (PIT) Regulations 2015.
2 months agoDisclosure under regulation 7(2) of SEBI (PIT) Regulations 2015.
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares & Stocks Pvt Ltd
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Desai Shares & Stocks Pvt Ltd
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-09-11
Dividend
1.0
2025-09-19
Dividend
1.0
2024-06-25
Dividend
1.0
2023-09-25
Dividend
0.75
Company details
Registered office
Survey No. 144 A Jarod - Samlaya Road Haripura, Savli Vadodara Gujarat PIN: 391520 Tel No: 02667 - 251670, 251680, 9909928332 Fax No: 02667 - 251679, 251680, 251669 Email: [email protected] / [email protected] Internet: www.bplindia.in
Registrars
18-20, 1st floor, Plot No 639,Makwana Road, Marol, Andheri (E),Mumbai – 400 059. MaharashtraTel: (022) 42270400Fax: (022) 28503748E-mail: [email protected]: www.adroitcorporate.com 18-20, 1st floor, Plot No 639 Makwana Road, Marol, Andheri (East) PIN: Tel No: (022) 42270400 Fax No: (022) 28503748 Email: NULL
Management
Sharmin Soni, Company Secretary & Compliance Officer
Bharat Desai, Chairman & Managing Director
Bharat Desai, Chairman & Managing Director
Hemang Shah, Executive Director
Zankhana Sheth, Non Executive Independent Director
Mukeshbhai Patel, Non Executive Independent Director
Alkesh Shah, Non Independent & Non Executive Director
Shailesh Kumar Ghabhawala, Non Executive Independent Director
Details
BSE 541096
NSE BPLPHARMA
ISIN INE365Y01019